Clinical Trial Update: Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing lapatinib plus chemotherapy to trastuzumab plus chemotherapy in HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Xijing Hospital | Conditions: Neoplasms, Breast | Phase 2 | Status: UNKNOWN